MedPath
NMPA Approval

Sorafenib Tosylate Tablets

国药准字H20213293

April 20, 2021

Drug Information

甲苯磺酸索拉非尼片

片剂

0.2g(以索拉非尼计)

化学药品

April 20, 2021

Company Information

Applicant Company

北京市北京经济技术开发区科创东六街97号

Manufacturing Company

北京市北京经济技术开发区科创东六街97号

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

甲苯磺酸索拉非尼片 - NMPA 批准文号 | MedPath